Scott Carnegie, Chairman and Finance Director, has over 25 years experience of advising on Fundraising and Business Restructuring for Small & Medium Sized Enterprises. During that time, he has also held several Executive Director roles with client companies giving him hands on experience in running businesses in several market sectors. He continues to sit on many Boards in both Executive and Non Executive capacities. In 2006, he founded, and is Chairman of Discovery Investment Fund- an angel group, which focuses on start-up and early stage investments. In 2013 he founded and is chairman of London Scottish Investment Partners, an angel group which focuses on helping later stage companies to grow and exit at value.
Dr Stewart White
Dr Stewart White CEO, has been working in life sciences for 20 years. Stewart has served as Chairman and CEO of several companies, and was founding CEO of AIM-listed Collagen Solutions plc. Stewart’s 20 years of experience includes commercialisation, product development and manufacturing of medical devices, advanced biologics and pharmaceuticals. Stewart is also a visiting lecturer at Glasgow University. He is a graduate of the University of Strathclyde and holds a first class BSc (Hons) in Applied Microbiology, a Ph.D. in Bioprocessing and an MBA. At Ocutec, we were delighted to welcome him in 2021.
Dr Roderick Bowers
Roderick Bowers, Science and business development director, is a veteran in the contact lens industry with over thirty years’ experience working with both multinational and start-ups in the biotech sector, in both the UK and the US. He was responsible for founding the Eyecare Division at Biocompatibles and the development and commercialisation of the Proclear product family, the business which was thence acquired by Coopervision for $100 Million Dollars. He has a number of key patents in the area of biomimetic materials for contact lenses and medical devices.
James H. Barton, Commercial Director, is a veteran of the contact lens industry, having spent twenty-two years as an executive at Bausch & Lomb Incorporated, where he served variously as Vice President of Business Development, overseeing all aspects of technology acquisition and managing numerous licensing deals; Vice President of Strategy and Commercial Development for Contact Lens, responsible for global product development, commercial launches, branding/pricing, and portfolio life-cycle management; and as leader of large marketing and sales organizations in both Japan and China. He is owner of James H. Barton Consulting, LLC and advises clients on biomedical technology commercialization.